{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:14:25Z","timestamp":1778130865223,"version":"3.51.4"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to report a case of diffuse subretinal fibrosis and uveitis (SFU) syndrome combined with vitreoretinal traction (VRT) syndrome, with a 4-year interval between the involvement of the two eyes in an elderly woman.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>A 67-year-old woman presented with sudden, painless vision loss in her left eye for 20\u202fdays. The right eye had experienced blurred vision for more than 4\u202fyears without treatment. Best-corrected visual acuity (BCVA) was 0.02 in the right eye and 0.05 in the left eye. Anterior segment examination was unremarkable, with no signs of anterior inflammation or iris nodules in either eye. In the right eye, clumps of white deposits behind the intraocular lens (IOL) and granular white opacities in the vitreous were observed. Diffuse yellowish-white subretinal lesions of varying sizes were present throughout the fundus, extending from the posterior pole to the far periphery, accompanied by scattered areas of hyperpigmentation and depigmentation. The lesion boundaries were relatively well defined. In the left eye, flocculent vitreous opacities were observed, some of which were adherent to the retina. Hemorrhages and scattered small yellowish-white subretinal lesions were present in the posterior fundus. Retinal degeneration was also noted in the mid-peripheral retina. Comprehensive ophthalmologic and systemic examinations were performed. Fundus fluorescein angiography (FFA) revealed secondary neovascular membranes in the posterior pole of the retina. However, systemic evaluation did not reveal any significant abnormalities. The patient was diagnosed with bilateral SFU syndrome, VRT syndrome, and retinal neovascularization in the left eye. Pars plana vitrectomy and intraocular injection of triamcinolone acetonide were performed. Postoperatively, systemic glucocorticoids and immunosuppressive therapy were administered. After more than 1\u202fyear of follow-up, the macular edema recurred repeatedly, while the subretinal fibrosis remained largely stable. Ultimately, this study also attempted anti-vascular endothelial growth factor (VEGF) therapy for macular edema and achieved a partial therapeutic effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SFU syndrome is a rare condition. The present case demonstrated a 4-year interval between bilateral onset and was further complicated by VRT syndrome and retinal neovascularization, features that have not been previously reported. Glucocorticoids and immunosuppressive agents may delay or alleviate subretinal fibrosis to some extent; anti-VEGF therapy can provide therapeutic benefit for macular edema in this disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1671793","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:56:10Z","timestamp":1778129770000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: A case of diffuse subretinal fibrosis and uveitis syndrome with vitreoretinal traction syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaohua","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Affiliated Hangzhou First People\u2019s Hospital, School of Medicine, Westlake University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongping","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Affiliated Hangzhou First People\u2019s Hospital, School of Medicine, Westlake University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Affiliated Hangzhou First People\u2019s Hospital, School of Medicine, Westlake University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"ref1","first-page":"797","volume-title":"Diagnosis and Treatment of Uveitis","author":"Rojas","year":"2002"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/bjo.68.9.667","article-title":"Progressive subretinal fibrosis and uveitis","volume":"68","author":"Palestine","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/00004397-199603610-00015","article-title":"The subretinal fibrosis and uveitis syndrome","volume":"36","author":"Kaiser","year":"1996","journal-title":"Int Ophthalmol Clin"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0002-9394(50)90700-8","article-title":"Choroiditis proliferans","volume":"33","author":"Fuchs","year":"1950","journal-title":"Am J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/09273948.2022.2043079","article-title":"Subretinal fibrosis in uveitis","volume":"30","author":"Cunningham","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/09273948.2021.2017152","article-title":"Risk factors for subretinal fibrosis in patients with Vogt Koyanagi Harada syndrome","volume":"29","author":"Golzarri","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1097\/IAE.0b013e3182437e54","article-title":"Diagnostic and therapeutic challenges","volume":"32","author":"Jhaveri","year":"2012","journal-title":"Retina"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/s0161-6420(86)33611-x","article-title":"Recurrent multifocal choroiditis","volume":"93","author":"Morgan","year":"1986","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/s0161-6420(00)00244-x","article-title":"Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease","volume":"107","author":"Kuo","year":"2000","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s004170050342","article-title":"Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome","volume":"237","author":"Lertsumitkul","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3109\/09273948.2013.872276","article-title":"Diffuse subretinal fibrosis and uveitis syndrome: successful treatment with adalimumab","volume":"22","author":"Ad\u00e1n","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/09273948.2019.1642492","article-title":"Rituximab in patients with refractory non-infectious uveitis: a multicenter study of 40 patients","volume":"28","author":"Lasave","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0002-9394(86)90590-8","article-title":"Multifocal choroiditis associated with progressive subretinal fibrosis","volume":"101","author":"Cantrill","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"ref14","first-page":"711","article-title":"Multifocal choroiditis with subretinal fibrosis","volume":"101","author":"Onoda","year":"1997","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"bcr2015212526","DOI":"10.1136\/bcr-2015-212526","article-title":"Multifocal chorioretinitis with progressive subretinal fibrosis in a young child","volume":"2015","author":"Steeples","year":"2015","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ajo.2004.04.013","article-title":"Immunopathology of progressive subretinal fibrosis: a variant of sympathetic ophthalmia","volume":"138","author":"Lim","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0002-9394(87)90287-x","article-title":"Histopathologic and immunohistopathologic features of subretinal fibrosis and uveitis syndrome","volume":"104","author":"Kim","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1177\/0036933014565582","article-title":"Unilateral subretinal fibrosis and uveitis syndrome","volume":"60","author":"Rehan","year":"2015","journal-title":"Scott Med J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00384-006-0137-2","article-title":"Subretinal fibrosis and uveitis syndrome associated with ulcerative colitis","volume":"22","author":"Fuentes-P\u00e1ez","year":"2007","journal-title":"Int J Color Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3109\/09273940903168670","article-title":"Subretinal fibrosis and uveitis syndrome in a patient with ectodermal dysplasia","volume":"17","author":"Huffman","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"Np1","DOI":"10.1177\/1120672118777418","article-title":"Diffuse subretinal fibrosis syndrome: a rare entity","volume":"28","author":"Stolowy","year":"2018","journal-title":"Eur J Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/icb.0000000000001111","article-title":"MULTI-MODAL IMAGING IN DIFFUSE SUBRETINAL FIBROSIS WITH UVEITIS SYNDROME","volume":"17","author":"Moll-Udina","year":"2023","journal-title":"Retin Cases Brief Rep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/bjophthalmol-2013-304686","article-title":"Treatment of diffuse subretinal fibrosis uveitis with rituximab","volume":"99","author":"Cornish","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.5858\/133.8.1233","article-title":"Intraocular lymphoma: diagnostic approach and immunophenotypic findings in vitrectomy specimens","volume":"133","author":"Raparia","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/IAE.0000000000001922","article-title":"Use of a threshold of interleukin-10 and IL-10\/IL-6 ratio in ocular samples for the diagnosis of primary intraocular lymphoma","volume":"155","author":"Pochat-Cotilloux","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/09273948.2022.2043079","article-title":"Vision loss in uveitis","volume":"30","author":"Cunningham","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00006982-200005000-00028","article-title":"Diffuse subretinal fibrosis syndrome","volume":"20","author":"Gandorfer","year":"2000","journal-title":"Retina"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1590\/s0004-27492006000300024","article-title":"Progressive subretinal fibrosis and multifocal granulomatous chorioretinitis","volume":"69","author":"Amaro","year":"2006","journal-title":"Arq Bras Oftalmol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ajo.2006.10.047","article-title":"Successful treatment with infliximab in a patient with diffuse subretinal fibrosis syndrome","volume":"143","author":"Ad\u00e1n","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3109\/09273948.2013.841959","article-title":"Subretinal fibrosis and uveitis: a spectral domain OCT study of its evolution and the minimal therapeutic effect of the off-label treatment with ranibizumab","volume":"22","author":"Symeonidis","year":"2014","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1671793\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:56:12Z","timestamp":1778129772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1671793\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":30,"alternative-id":["10.3389\/fmed.2026.1671793"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1671793","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"article-number":"1671793"}}